-
1
-
-
0021951262
-
Cerebrovascular complications in patients with cancer
-
Graus F, Rogers L, Posner J. Cerebrovascular complications in patients with cancer. Medicine 1985;64:16-35.
-
(1985)
Medicine
, vol.64
, pp. 16-35
-
-
Graus, F.1
Rogers, L.2
Posner, J.3
-
2
-
-
0027486845
-
Predictive factors of a complete response to an adverse effect of a CDDP-5FU combination as primary therapy for head and neck squamous carcinomas
-
Bachaud JM, David JM, Shubinski RE, et al. Predictive factors of a complete response to an adverse effect of a CDDP-5FU combination as primary therapy for head and neck squamous carcinomas. J Laryngol Otol 1993;107:924-930.
-
(1993)
J Laryngol Otol
, vol.107
, pp. 924-930
-
-
Bachaud, J.M.1
David, J.M.2
Shubinski, R.E.3
-
3
-
-
0022550128
-
Vascular toxicity associated with antineoplastic agents
-
Doll DC, Ringenberg QS, Yarbo JW. Vascular toxicity associated with antineoplastic agents. J Clin Oncol 1986;4:1405-1417.
-
(1986)
J Clin Oncol
, vol.4
, pp. 1405-1417
-
-
Doll, D.C.1
Ringenberg, Q.S.2
Yarbo, J.W.3
-
5
-
-
0027294629
-
Severe vascular toxicity associated with cisplatin-based chemotherapy
-
Içli F, Karaoguz H, Dinçol D, et al. Severe vascular toxicity associated with cisplatin-based chemotherapy. Cancer 1993; 72:587-593.
-
(1993)
Cancer
, vol.72
, pp. 587-593
-
-
Içli, F.1
Karaoguz, H.2
Dinçol, D.3
-
6
-
-
0025791926
-
High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association
-
Atkins JN, Muss HB, Case D, et al. High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association. Am J Clin Oncol 1991;14:526-529.
-
(1991)
Am J Clin Oncol
, vol.14
, pp. 526-529
-
-
Atkins, J.N.1
Muss, H.B.2
Case, D.3
-
7
-
-
0029783365
-
Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer
-
Pritchard KI, Paterson AHG, Paul NA, Zee B, Fine S, Pater J, for the National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. J Clin Oncol 1996;14:2731-2737.
-
(1996)
J Clin Oncol
, vol.14
, pp. 2731-2737
-
-
Pritchard, K.I.1
Paterson, A.H.G.2
Paul, N.A.3
Zee, B.4
Fine, S.5
Pater, J.6
-
8
-
-
0023374408
-
Cardiotoxicity of 5-fluorouracil
-
Collins C, Welden PL. Cardiotoxicity of 5-fluorouracil. Cancer Treat Rep 1987;71:733-736.
-
(1987)
Cancer Treat Rep
, vol.71
, pp. 733-736
-
-
Collins, C.1
Welden, P.L.2
-
9
-
-
0023740595
-
Adverse cardiac effects during induction chemotherapy treatment with cisplatin and 5-fluorouracil
-
Eskilsson J, Albertsson M, Mercke C. Adverse cardiac effects during induction chemotherapy treatment with cisplatin and 5-fluorouracil. Radiother Oncol 1988;13:41-46.
-
(1988)
Radiother Oncol
, vol.13
, pp. 41-46
-
-
Eskilsson, J.1
Albertsson, M.2
Mercke, C.3
-
10
-
-
0023254077
-
5-Fluorouracil induced coronary vasospasm
-
Burger A, Mannino S. 5-Fluorouracil induced coronary vasospasm. Am Heart J 1987;114:433-436.
-
(1987)
Am Heart J
, vol.114
, pp. 433-436
-
-
Burger, A.1
Mannino, S.2
|